With SynergyMed's noninvasive tumor treatment, this furry companion received effective and precise care leading to a quicker and healthier recovery.

There are over 12,000,000 yearly new cancer cases for cats and dogs in the US. About 70% of US households own a pet.
Surgical solutions are risky due bleeding complications, infections, wound dehiscence, and dirty margins.
The non-surgical solution of SynergyMed will serve an unmet need for veterinary companion animals and horses with superficial solid tumors.


A 6-year-old dog with breast cancer tumor was treated by SynergyMed technology. The dog is healthy and happy.

Our veterinary device utilizes cutting-edge technology, providing a noninvasive, precise, and effective way to treat superficial solid tumors in companion animals, and wildlife animals. With the use of FDA-approved nanoparticles and specialized electromagnetic applicators, we can ablate and destroy cancerous tumors without harming the surrounding healthy tissue. Our technology has shown promising results in clinical studies on dogs, and we are excited to continue our mission of providing a safer and more humane way to treat cancer in animals.

The company started clinical studies on dogs with very promising results so far. If you are an animal research veterinary hospital in the North East region of the United States, and would like to join our studies, let us know by contacting us at the link below.

Feel Free To Reach Out To Us.